Predispositions to Colorectal Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
There is a dramatically uneven distribution of risk among women for colorectal cancer, the second most common cancer in America. Low-risk women have only five percent lifetime odds of developing the disease, while moderate and high-risk subsets are much more vulnerable. What accounts for this risk? The evidence points to a series of genetic and environmental factors, along with other known syndromes. Dr. Steven Stryker, professor of clinical oncology at Northwestern University’s Feinberg School of Medicine, joins host Dr. Lauren Streicher to evaluate common predispositions to this devastating disease.
Overview
There is a dramatically uneven distribution of risk among women for colorectal cancer, the second most common cancer in America. Low-risk women have only five percent lifetime odds of developing the disease, while moderate and high-risk subsets are much more vulnerable. What accounts for this risk? The evidence points to a series of genetic and environmental factors, along with other known syndromes. Dr. Steven Stryker, professor of clinical oncology at Northwestern University’s Feinberg School of Medicine, joins host Dr. Lauren Streicher to evaluate common predispositions to this devastating disease.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?